SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.219B
March 31, 2026 2.221B
December 31, 2025 2.216B
September 30, 2025 2.273B
June 30, 2025 2.289B
March 31, 2025 2.268B
December 31, 2024 2.23B
September 30, 2024 2.168B
June 30, 2024 2.125B
March 31, 2024 2.073B
December 31, 2023 2.021B
September 30, 2023 2.025B
June 30, 2023 1.953B
March 31, 2023 1.879B
December 31, 2022 1.886B
September 30, 2022 1.893B
June 30, 2022 1.960B
March 31, 2022 1.986B
December 31, 2021 1.952B
September 30, 2021 1.926B
June 30, 2021 1.826B
March 31, 2021 1.764B
December 31, 2020 1.729B
September 30, 2020 1.625B
June 30, 2020 1.607B
Date Value
March 31, 2020 1.626B
December 31, 2019 1.624B
September 30, 2019 1.608B
June 30, 2019 1.588B
March 31, 2019 1.568B
December 31, 2018 1.571B
September 30, 2018 1.591B
June 30, 2018 1.591B
March 31, 2018 1.553B
December 31, 2017 1.499B
September 30, 2017 1.488B
June 30, 2017 1.507B
March 31, 2017 1.559B
December 31, 2016 1.630B
September 30, 2016 1.630B
June 30, 2016 1.616B
March 31, 2016 1.598B
December 31, 2015 1.599B
September 30, 2015 1.503B
June 30, 2015 1.423B
March 31, 2015 1.328B
December 31, 2014 1.198B
September 30, 2014 1.174B
June 30, 2014 1.148B
March 31, 2014 1.130B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Quest Diagnostics, Inc. 2.038B
DaVita, Inc. 1.732B
OPKO Health, Inc. 205.85M
Psychemedics Corp. --
NeoGenomics, Inc. 359.09M